Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-12/IL-12R system in multiple sclerosis.

V Ozenci1, M Pashenkov, M Kouwenhoven

  • 1Neuroimmunology Unit, Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden. volkan.ozenci@neurotec.ki.se

Journal of Neuroimmunology
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Nature immunology·2001
Same author

Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.

Scandinavian journal of gastroenterology·2000
Same author

Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.

Clinical immunology (Orlando, Fla.)·2000
Same author

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group.

Leukemia·2000
Same author

IL-12 elispot assays to detect and enumerate IL-12 secreting cells.

Cytokine·2000
Same author

Double minutes and c-MYC amplification in acute myelogenous leukemia: Are they prognostic factors?

Cancer genetics and cytogenetics·2000
Same journal

Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue.

Journal of neuroimmunology·2026
Same journal

Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE).

Journal of neuroimmunology·2026
Same journal

Thymectomy promotes maintained complete stable remission in myasthenia gravis.

Journal of neuroimmunology·2026
Same journal

Spinal cord microglia exhibit a dysfunctional response to myelin damage.

Journal of neuroimmunology·2026
Same journal

Methodological concerns in the cutoff determination of a flow cytometric MOG-IgG assay: The need for independent validation.

Journal of neuroimmunology·2026
Same journal

Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.

Journal of neuroimmunology·2026
See all related articles

Multiple sclerosis patients show increased IL-12 receptor expression on T cells. This suggests a dysregulated IL-12/IL-12 receptor system may augment the immune response in MS.

Area of Science:

  • Immunology
  • Neuroimmunology
  • Molecular Biology

Background:

  • The interleukin-12 (IL-12)/IL-12 receptor (IL-12R) system is crucial for the T-helper 1 (Th1) immune pathway, bridging innate and adaptive immunity.
  • Understanding the IL-12/IL-12R system's role in neurological diseases like multiple sclerosis (MS) is important for therapeutic development.

Purpose of the Study:

  • To investigate the expression and function of the IL-12/IL-12R system components in patients with multiple sclerosis (MS) compared to healthy controls.
  • To determine if alterations in IL-12 receptor expression correlate with disease activity or immune cell function in MS.

Main Methods:

  • Analysis of IL-12 receptor beta 1 (IL-12Rbeta1) and IL-12Rbeta2 expression on peripheral blood and cerebrospinal fluid (CSF) T cells from MS patients and controls.

Related Experiment Videos

  • Quantification of IL-12 secreting blood mononuclear cells (MNCs).
  • Assessment of IL-12-induced interferon-gamma (IFN-gamma) production and T cell proliferation in relation to IL-12Rbeta2 expression.

    • Main Results:

    • MS patients exhibited significantly higher IL-12Rbeta1 and IL-12Rbeta2 expression on PHA-activated T cells compared to healthy subjects.
    • Elevated percentages of IL-12Rbeta1 and IL-12Rbeta2 positive T cells were found in CSF compared to blood in both MS and other neurological disease (OND) patients.
    • IL-12-stimulated IFN-gamma production and T cell proliferation in MS patients positively correlated with IL-12Rbeta2 expression levels.

    Conclusions:

    • The study indicates a dysregulation of the IL-12/IL-12R system in the context of multiple sclerosis.
    • Elevated IL-12 receptor expression, particularly IL-12Rbeta2, may enhance the net effect of IL-12 signaling in MS, even without increased IL-12 levels.
    • These findings highlight the potential therapeutic relevance of targeting the IL-12/IL-12R pathway in MS.